Michael Wiederhorn
Stock Analyst at Oppenheimer
(3.59)
# 693
Out of 4,820 analysts
138
Total ratings
50.75%
Success rate
2.99%
Average return
Main Sectors:
Stocks Rated by Michael Wiederhorn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintains: Outperform | $640 → $600 | $417.99 | +43.54% | 15 | Apr 21, 2025 | |
| CI The Cigna Group | Maintains: Outperform | $400 → $375 | $335.63 | +11.73% | 11 | Jan 31, 2025 | |
| TDOC Teladoc Health | Maintains: Outperform | $14 → $12 | $7.21 | +66.44% | 11 | Jan 24, 2025 | |
| CNC Centene | Maintains: Outperform | $95 → $85 | $57.40 | +48.08% | 17 | Dec 13, 2024 | |
| PNTG The Pennant Group | Maintains: Outperform | $34 → $37 | $25.39 | +45.73% | 6 | Nov 8, 2024 | |
| HCA HCA Healthcare | Maintains: Outperform | $390 → $400 | $323.64 | +23.59% | 11 | Oct 28, 2024 | |
| ENSG The Ensign Group | Maintains: Outperform | $165 → $168 | $125.70 | +33.65% | 8 | Oct 25, 2024 | |
| HUM Humana | Maintains: Outperform | $400 → $280 | $264.64 | +5.80% | 12 | Oct 3, 2024 | |
| ADUS Addus HomeCare | Maintains: Outperform | $140 → $145 | $100.40 | +44.42% | 10 | Sep 23, 2024 | |
| PACS PACS Group | Maintains: Outperform | $32 → $40 | $9.43 | +324.18% | 3 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $4.5 → $5 | $2.66 | +87.97% | 10 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Perform | n/a | $7.74 | - | 2 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $625 → $650 | $543.51 | +19.59% | 12 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $145 | $94.25 | +53.85% | 10 | Oct 28, 2022 |
UnitedHealth Group
Apr 21, 2025
Maintains: Outperform
Price Target: $640 → $600
Current: $417.99
Upside: +43.54%
The Cigna Group
Jan 31, 2025
Maintains: Outperform
Price Target: $400 → $375
Current: $335.63
Upside: +11.73%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $14 → $12
Current: $7.21
Upside: +66.44%
Centene
Dec 13, 2024
Maintains: Outperform
Price Target: $95 → $85
Current: $57.40
Upside: +48.08%
The Pennant Group
Nov 8, 2024
Maintains: Outperform
Price Target: $34 → $37
Current: $25.39
Upside: +45.73%
HCA Healthcare
Oct 28, 2024
Maintains: Outperform
Price Target: $390 → $400
Current: $323.64
Upside: +23.59%
The Ensign Group
Oct 25, 2024
Maintains: Outperform
Price Target: $165 → $168
Current: $125.70
Upside: +33.65%
Humana
Oct 3, 2024
Maintains: Outperform
Price Target: $400 → $280
Current: $264.64
Upside: +5.80%
Addus HomeCare
Sep 23, 2024
Maintains: Outperform
Price Target: $140 → $145
Current: $100.40
Upside: +44.42%
PACS Group
Aug 13, 2024
Maintains: Outperform
Price Target: $32 → $40
Current: $9.43
Upside: +324.18%
Jul 25, 2024
Maintains: Outperform
Price Target: $4.5 → $5
Current: $2.66
Upside: +87.97%
Mar 7, 2024
Maintains: Perform
Price Target: n/a
Current: $7.74
Upside: -
Feb 29, 2024
Maintains: Outperform
Price Target: $625 → $650
Current: $543.51
Upside: +19.59%
Oct 28, 2022
Maintains: Outperform
Price Target: $175 → $145
Current: $94.25
Upside: +53.85%